Novel-Policy Cost-Benefit Analyses

Recently completed, publicly-viewable projects:

• Cost-Benefit Analysis of Synthetic Nucleic Acid Screening for the UK
• Cost–Benefit Analysis for Synthetic Nucleic Acid Screening in the European Union

Peer-Reviewed Papers

• Mpox Vaccine Stockpile Simulation and Cost-Benefit Analysis (under review)
• Risk modeling for ASHRAE Standard 241-2023 — Control of infectious aerosols

Policy Development

• Model Clean Indoor Air Act

Pro Bono

• CalSHAPE